Stay updated on Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial page.

Latest updates to the Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision log updated: added Revision v3.5.0; removed Revision v3.4.3.SummaryDifference0.0%

- Check16 days agoChange DetectedRevision update applied: v3.4.3 replacing the previous v3.4.2.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check45 days agoChange DetectedAdded Revision: v3.4.2; removed the funding-lapse notice and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check52 days agoChange DetectedAdded a general funding-status notice at the top of the page. Updated the page to version 3.4.1 and removed the 3.4.0 reference.SummaryDifference0.2%

- Check59 days agoChange DetectedThe page now includes a glossary toggle and new metadata labels such as 'Last Update Submitted that Met QC Criteria' and 'Last Update Posted', along with 'No FEAR Act Data' and a revision tag 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision: v3.3.4 replaces v3.3.3; no user-visible changes to the Study Details page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial page.